{
  "meta": {
    "id": "test62",
    "title": "Mediators of Inflammation",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "Which cell-derived chemical mediators of inflammation are not performed in secretory granules?",
      "options": [
        {
          "label": "A",
          "text": "Histamine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lysosomal enzymes",
          "correct": false
        },
        {
          "label": "C",
          "text": "Leukotrienes",
          "correct": true
        },
        {
          "label": "D",
          "text": "Myeloperoxidase",
          "correct": false
        }
      ],
      "correct_answer": "C. Leukotrienes",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Leukotrienes Mediators are either secreted by cells or generated from plasma proteins . Cell-derived mediators are normally sequestered in intracellular granules . They can be rapidly secreted by granule exocytosis (g., histamine in mast cell granules) or synthesised de novo (e.g., prostaglandins, leukotrienes, and cytokines) in response to a stimulus. Leukotrienes are produced in leukocytes and mast cells by the action of lipoxygenase and are involved in vascular and smooth muscle reactions and leukocyte recruitment, synthesised de novo . Mediators of inflammation: Cell-derived Preformed Histamine Serotonin Primary and secondary granules of neutrophils Synthesised de novo NO Platelet-activating factor (PAF) Arachidonic acid metabolite ( Leukotrienes and Prostaglandins) Interleukins/Cytokines Plasma-derived Complements Kinins Coagulation factors</p>\n<p><strong>Highyeild:</strong></p><p>Source of inflammatory mediators: Mediator Source Action Histamine Mast cells, basophils, platelets Vasodilation, increased vascular permeability, endothelial activation Prostaglandins Mast cells, leukocytes Vasodilation, pain, fever Leukotrienes Mast cells, leukocytes Increased vascular permeability, chemotaxis, leukocyte adhesion and activation Cytokines (TNF, IL-1, IL-6) Macrophages, endothelial cells, mast cells Local: endothelial activation (expression of adhesion molecules) Systemic: fever, metabolic abnormalities, hypotension (shock) Chemokines Leukocytes, activated macrophages Chemotaxis, leukocyte activation Platelet- activating factor Leukocytes, mast cells Vasodilation, increased vascular permeability, leukocyte adhesion, chemotaxis, degranulation, oxidative burst Complement Plasma (produced in liver) Leukocyte chemotaxis and activation, direct target killing (membrane attack complex), vasodilation (mast cell stimulation) Kinins Plasma (produced in liver Increased vascular permeability, smooth muscle contraction, vasodilation, pain</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Histamine. Preformed mediator . Option: B. Lysosomal enzymes. Preformed mediator . Option: D. Myeloperoxidase. Primary granules in neutrophil . Preformed mediator .</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f8056fcf",
      "audio": ""
    },
    {
      "text": "Which of the following is an Opsonin?",
      "options": [
        {
          "label": "A",
          "text": "C3a",
          "correct": false
        },
        {
          "label": "B",
          "text": "C3b",
          "correct": true
        },
        {
          "label": "C",
          "text": "C5a",
          "correct": false
        },
        {
          "label": "D",
          "text": "LTC4",
          "correct": false
        }
      ],
      "correct_answer": "B. C3b",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>C3b Opsonisation and phagocytosis: C3b and its cleavage product iC3b (inactive C3b), when fixed to a microbial cell wall, act as opsonins and promote phagocytosis by neutrophils and macrophages , which bear cell surface receptors for the complement fragments. Phagocytosis efficiency is greatly enhanced when microbes are coated with opsonins for which the phagocytes express high-affinity receptors. The major opsonins are: IgM and Fc receptors of IgG C3b breakdown product of complement ( C3a, C4b, C5b ) Mannose-binding lectin Fibrinogen C- Reactive Protein ( CRP )</p>\n<p><strong>Highyeild:</strong></p><p>Role of inflammatory mediators: table,tr,th,td {border:1px solid black;} Reaction of Inflammation Principal Mediators Vasodilation Histamine Prostaglandins Increased vascular permeability Histamine and serotonin C3a and C5a (by liberating vasoactive amines from mast cells, other cells) Leukotrienes C4, D4, E4 Chemotaxis, leukocyte recruitment and activation TNF, IL-I Chemokines C3a, C5a Leukotriene B4 Fever IL-1, TNF Prostaglandins Pain Prostaglandins Bradykinin Substance P Tissue damage Lysosomal enzymes of leukocytes Reactive oxygen species Role of Arachidonic Acid Metabolites: Action Eicosanoid Vasodilation Prostaglandins PGI2 (prostacyclin), PGE,, PGE2, PGD2 Vasoconstriction Thromboxane A2, leukotrienes C4, D4, E4 Increased vascular permeability Leukotrienes C4, D4, E4 Chemotaxis, leukocyte adhesion Leukotrienes B4, HETE HETE, Hydroxyeicosatetraenoic acid.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. C3a. Anaphylatoxin . Option: B. C5a. Chemotactic agent for neutrophils, monocytes, eosinophils, basophils, and Anaphylatoxin . Option: C. LTC4. Leukotriene C4 Intense vasoconstriction, bronchospasm (important in asthma) , and increased permeability of venules.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5417c5cd",
      "audio": ""
    },
    {
      "text": "Which of the following complement is a chemokine as well as anaphylatoxin?",
      "options": [
        {
          "label": "A",
          "text": "C3a",
          "correct": false
        },
        {
          "label": "B",
          "text": "C3b",
          "correct": false
        },
        {
          "label": "C",
          "text": "C5a",
          "correct": true
        },
        {
          "label": "D",
          "text": "C5b",
          "correct": false
        }
      ],
      "correct_answer": "C. C5a",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>C5a C5a , C3a, and, to a lesser extent, C4a are cleavage products of the corresponding complement components that stimulate histamine release from mast cells and thereby increase vascular permeability and cause vasodilation . C5a is also a chemotactic agent for neutrophils, monocytes, eosinophils, and basophils. C5a is both a Chemokine and Anaphylatoxin .</p>\n<p><strong>Highyeild:</strong></p><p>Role of inflammatory mediators: table,tr,th,td {border:1px solid black;} Reaction of Inflammation Principal Mediators Vasodilation Histamine Prostaglandins Increased vascular permeability Histamine and serotonin C3a and C5a (by liberating vasoactive amines from mast cells, other cells) Leukotrienes C4, D4, E4 Chemotaxis, leukocyte recruitment and activation TNF, IL-I Chemokines C3a, C5a Leukotriene B4 Fever IL-1, TNF Prostaglandins Pain Prostaglandins Bradykinin Substance P Tissue damage Lysosomal enzymes of leukocytes Reactive oxygen species Role of Arachidonic Acid Metabolites: Action Eicosanoid Vasodilation Prostaglandins PGI2 (prostacyclin), PGE,, PGE2, PGD2 Vasoconstriction Thromboxane A2, leukotrienes C4, D4, E4 Increased vascular permeability Leukotrienes C4, D4, E4 Chemotaxis, leukocyte adhesion Leukotrienes B4, HETE HETE, Hydroxyeicosatetraenoic acid.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. C3a. It is an anaphylatoxin only , not a chemokine. Option: C3b. Opsonin . Op tion: D. C5b. Opsonin .</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e4f419ef",
      "audio": ""
    },
    {
      "text": "Which of the following is the function of bradykinin?",
      "options": [
        {
          "label": "A",
          "text": "Increased vascular permeability",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pain",
          "correct": false
        },
        {
          "label": "C",
          "text": "Vasodilation",
          "correct": false
        },
        {
          "label": "D",
          "text": "All of the above",
          "correct": true
        }
      ],
      "correct_answer": "D. All of the above",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>All of the above Bradykinin increases vascular permeability and causes contraction of smooth muscle, dilation of blood vessels, and pain when injected into the skin . These effects are similar to those of histamine. The action of bradykinin is short-lived because it is quickly inactivated by an enzyme called kininase .</p>\n<p><strong>Highyeild:</strong></p><p>Role of inflammatory mediators: table,tr,th,td {border:1px solid black;} Reaction of Inflammation Principal Mediators Vasodilation Histamine Prostaglandins Increased vascular permeability Histamine and serotonin C3a and C5a (by liberating vasoactive amines from mast cells, other cells) Leukotrienes C4, D4, E4 Chemotaxis, leukocyte recruitment and activation TNF, IL-I Chemokines C3a, C5a Leukotriene B4 Fever IL-1, TNF Prostaglandins Pain Prostaglandins Bradykinin Substance P Tissue damage Lysosomal enzymes of leukocytes Reactive oxygen species Role of Arachidonic Acid Metabolites: Action Eicosanoid Vasodilation Prostaglandins PGI2 (prostacyclin), PGE,, PGE2, PGD2 Vasoconstriction Thromboxane A2, leukotrienes C4, D4, E4 Increased vascular permeability Leukotrienes C4, D4, E4 Chemotaxis, leukocyte adhesion Leukotrienes B4, HETE HETE, Hydroxyeicosatetraenoic acid.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Increased vascular permeability. True . Option: B. Pain. True . Option: C. Vasodilation. True</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "12a72714",
      "audio": ""
    },
    {
      "text": "Which of the following statements is true regarding bradykinin?",
      "options": [
        {
          "label": "A",
          "text": "Kininogen converts kallikrein to kinin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Bradykinin increases skeletal muscle contraction",
          "correct": false
        },
        {
          "label": "C",
          "text": "Its effects are similar to serotonin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Its action is short-lived",
          "correct": true
        }
      ],
      "correct_answer": "D. Its action is short-lived",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Its action is short-lived The action of bradykinin is short-lived because it is quickly inactivated by an enzyme called kininase. Bradykinin has been implicated as a mediator in some forms of allergic reactions, such as anaphylaxis.</p>\n<p><strong>Highyeild:</strong></p><p>Role of inflammatory mediators: table,tr,th,td {border:1px solid black;} Reaction of Inflammation Principal Mediators Vasodilation Histamine Prostaglandins Increased vascular permeability Histamine and serotonin C3a and C5a (by liberating vasoactive amines from mast cells, other cells) Leukotrienes C4, D4, E4 Chemotaxis, leukocyte recruitment and activation TNF, IL-I Chemokines C3a, C5a Leukotriene B4 Fever IL-1, TNF Prostaglandins Pain Prostaglandins Bradykinin Substance P Tissue damage Lysosomal enzymes of leukocytes Reactive oxygen species Role of Arachidonic Acid Metabolites: Action Eicosanoid Vasodilation Prostaglandins PGI2 (prostacyclin), PGE,, PGE2, PGD2 Vasoconstriction Thromboxane A2, leukotrienes C4, D4, E4 Increased vascular permeability Leukotrienes C4, D4, E4 Chemotaxis, leukocyte adhesion Leukotrienes B4, HETE HETE, Hydroxyeicosatetraenoic acid.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Kininogen converts kallikrein to kinin. Kinins are vasoactive peptides derived from plasma proteins , called kininogens , by the action of specific proteases called kallikrein . The enzyme kallikrein cleaves a plasma glycoprotein precursor, high-molecular-weight kininogen, to produce bradykinin . Option: B. Bradykinin increases skeletal muscle contraction. Bradykinin increases vascular permeability and causes the contraction of smooth muscle Option: C. Its effects are similar to serotonin. The effects are similar to those of histamine . Serotonin (5-hydroxytryptamine) is a preformed vasoactive mediator in platelets and specific neuroendocrine cells, such as the gastrointestinal tract.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "392b46bf",
      "audio": ""
    },
    {
      "text": "Histamine and serotonin are secreted by the following cells, respectively?",
      "options": [
        {
          "label": "A",
          "text": "Platelets, Enterochromaffin cells",
          "correct": false
        },
        {
          "label": "B",
          "text": "Enterochromaffin cells, Endothelium",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mast cells, Enterochromaffin cells",
          "correct": true
        },
        {
          "label": "D",
          "text": "Mast cells, Endothelium",
          "correct": false
        }
      ],
      "correct_answer": "C. Mast cells, Enterochromaffin cells",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Mast cells, Enterochromaffin cells The two primary vasoactive amines , so named because they have important actions on blood vessels, are histamine and serotonin . The richest source of histamine in mast cells is generally present in the connective tissue adjacent to blood vessels and in basophils and platelets. Serotonin (5-hydroxytryptamine) is a preformed vasoactive mediator in platelets and specific neuroendocrine cells, such as the gastrointestinal tract .</p>\n<p><strong>Highyeild:</strong></p><p>Mediator Source Action Histamine Mast cells, basophils, platelets Vasodilation, increased vascular permeability, endothelial activation Prostaglandins Mast cells, leukocytes Vasodilation, pain, fever Leukotrienes Mast cells, leukocytes Increased vascular permeability, chemotaxis, leukocyte adhesion and activation Cytokines (TNF, IL-1, IL-6) Macrophages, endothelial cells, mast cells Local: endothelial activation (expression of adhesion molecules) Systemic: fever, metabolic abnormalities, hypotension (shock) Chemokines Leukocytes, activated macrophages Chemotaxis, leukocyte activation Platelet- activating factor Leukocytes, mast cells Vasodilation, increased vascular permeability, leukocyte adhesion, chemotaxis, degranulation, oxidative burst Complement Plasma (produced in liver) Leukocyte chemotaxis and activation, direct target killing (membrane attack complex), vasodilation (mast cell stimulation) Kinins Plasma (produced in liver Increased vascular permeability, smooth muscle contraction, vasodilation, pain</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Platelets, Enterochromaffin cells. Incorrect . Option: B. Enterochromaffin cells, Endothelium. Incorrect . Option: D. Mast cells, Endothelium. Incorrect .</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5d998326",
      "audio": ""
    },
    {
      "text": "Nitric oxide is synthesised by -",
      "options": [
        {
          "label": "A",
          "text": "Citrulline",
          "correct": false
        },
        {
          "label": "B",
          "text": "Asparagine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Arginine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Ornithine",
          "correct": false
        }
      ],
      "correct_answer": "C. Arginine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Arginine NO , a soluble gas produced from arginine by the action of nitric oxide synthase (NOS) , also participates in microbial killing. In addition to its role as a microbicidal substance, NO relaxes vascular smooth muscle and promotes vasodilation.</p>\n<p><strong>Highyeild:</strong></p><p>NO is synthesised from Arginine . Sites: Endothelium (eNO): Maintains vascular tone Nerves (nNO): Neurotransmitter Inducible (iNO): Inflammation Functions: Vasodilation Smooth muscle relaxation Reactive Oxygen Species</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Citrulline. Using nitric oxide synthase, arginine converts Arginine into Citrulline and releases NO. Option: Asparagine. Incorrect . Option: D. Ornithine. Incorrect option.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c10be39b",
      "audio": ""
    },
    {
      "text": "Which of the following is not a function of NO?",
      "options": [
        {
          "label": "A",
          "text": "Vasodilation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Neurotransmission",
          "correct": false
        },
        {
          "label": "C",
          "text": "Decrease platelets aggregation",
          "correct": false
        },
        {
          "label": "D",
          "text": "None of the above",
          "correct": true
        }
      ],
      "correct_answer": "D. None of the above",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>None of the above NO , a soluble gas produced from arginine by the action of nitric oxide synthase (NOS) , also participates in microbial killing. In addition to its role as a microbicidal substance, NO relaxes vascular smooth muscle and promotes vasodilation.</p>\n<p><strong>Highyeild:</strong></p><p>NO is synthesised from Arginine . Sites: Endothelium (eNO): Maintains vascular tone Nerves (nNO): Neurotransmitter Inducible (iNO): Inflammation Functions: Vasodilation Smooth muscle relaxation Reactive Oxygen Species</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Vasodilation. True . Option: B. Neurotransmission. True . Option: C. Decrease platelet aggregation. True .</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "94601786",
      "audio": ""
    },
    {
      "text": "Which of the following is true regarding Platelet Activating Factor?",
      "options": [
        {
          "label": "A",
          "text": "It causes vasodilation at high concentrations",
          "correct": false
        },
        {
          "label": "B",
          "text": "It is released by platelets only",
          "correct": false
        },
        {
          "label": "C",
          "text": "At low concentrations, it causes vasoconstriction",
          "correct": false
        },
        {
          "label": "D",
          "text": "It can also cause bronchoconstriction",
          "correct": true
        }
      ],
      "correct_answer": "D. It can also cause bronchoconstriction",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>It can also cause bronchoconstriction Platelet-activating factor (PAF) is a phospholipid-derived mediator. In addition to platelet aggregation , PAF causes vasoconstriction and bronchoconstriction , and at low concentrations, it induces vasodilation and increased venular permeability .</p>\n<p><strong>Highyeild:</strong></p><p>Mediator Source Action Histamine Mast cells, basophils, platelets Vasodilation, increased vascular permeability, endothelial activation Prostaglandins Mast cells, leukocytes Vasodilation, pain, fever Leukotrienes Mast cells, leukocytes Increased vascular permeability, chemotaxis, leukocyte adhesion and activation Cytokines (TNF, IL-1, IL-6) Macrophages, endothelial cells, mast cells Local: endothelial activation (expression of adhesion molecules) Systemic: fever, metabolic abnormalities, hypotension (shock) Chemokines Leukocytes, activated macrophages Chemotaxis, leukocyte activation Platelet- activating factor Leukocytes, mast cells Vasodilation, increased vascular permeability, leukocyte adhesion, chemotaxis, degranulation, oxidative burst Complement Plasma (produced in liver) Leukocyte chemotaxis and activation, direct target killing (membrane attack complex), vasodilation (mast cell stimulation) Kinins Plasma (produced in liver Increased vascular permeability, smooth muscle contraction, vasodilation, pain</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: It causes vasodilation at high concentrations. It causes vasodilation and increased venular permeability at low concentrations . Option: B . It is released by platelets only. Cell types, including platelets, basophils, mast cells, neutrophils, macrophages, and endothelial cells , can elaborate PAF in both secreted and cell-bound forms. Option: C . At low concentrations, it causes vasoconstriction. It causes vasoconstriction and platelet aggregation at high concentrations .</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fa6854f6",
      "audio": ""
    },
    {
      "text": "What are the mediators formed by the Cyclooxygenase pathway, named a,b, and c respectively given in the Image given below?",
      "options": [
        {
          "label": "A",
          "text": "PGD2, PGI2, PAGE2",
          "correct": false
        },
        {
          "label": "B",
          "text": "PGD2, PAGE2, PGI2",
          "correct": false
        },
        {
          "label": "C",
          "text": "TXA2, PGI2, PGD2",
          "correct": false
        },
        {
          "label": "D",
          "text": "PGI2, TXA2, PGD2",
          "correct": true
        }
      ],
      "correct_answer": "D. PGI2, TXA2, PGD2",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/questionImage-1742890648445-photos-1686815707449-QTDP019014IMG1(2).png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>PGI2, TXA2, PGD2 Platelets contain the enzyme thromboxane synthase , and hence TxA2 is the major product in these cells. TxA2 , a potent platelet-aggregating agent and vasoconstrictor , is unstable and rapidly converted to an inactive form. The vascular endothelium lacks thromboxane synthase but contains prostacyclin synthase , which is responsible for the formation of prostacyclin (PGI2) and its stable end product PGF1a. Prostacyclin is a vasodilator and a potent inhibitor of platelet aggregation and also markedly potentiates the permeability-increasing and chemotactic effects of other mediators. PGD2 is the major prostaglandin made by mast cells ; along with PAGE2, it causes vasodilation and increases the permeability of postcapillary venules, thus potentiating edema formation . PGD2 also is a chemoattractant for neutrophils .</p>\n<p><strong>Highyeild:</strong></p><p>Mediator Source Action Histamine Mast cells, basophils, platelets Vasodilation, increased vascular permeability, endothelial activation Prostaglandins Mast cells, leukocytes Vasodilation, pain, fever Leukotrienes Mast cells, leukocytes Increased vascular permeability, chemotaxis, leukocyte adhesion and activation Cytokines (TNF, IL-1, IL-6) Macrophages, endothelial cells, mast cells Local: endothelial activation (expression of adhesion molecules) Systemic: fever, metabolic abnormalities, hypotension (shock) Chemokines Leukocytes, activated macrophages Chemotaxis, leukocyte activation Platelet- activating factor Leukocytes, mast cells Vasodilation, increased vascular permeability, leukocyte adhesion, chemotaxis, degranulation, oxidative burst Complement Plasma (produced in liver) Leukocyte chemotaxis and activation, direct target killing (membrane attack complex), vasodilation (mast cell stimulation) Kinins Plasma (produced in liver Increased vascular permeability, smooth muscle contraction, vasodilation, pain</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Options A, B, D are incorrect</p>\n<p><strong>Extraedge:</strong></p><p>Role of Arachidonic Acid Metabolites: table,tr,th,td {border:1px solid black;} Action Eicosanoid Vasodilation Prostaglandins PGI2 (prostacyclin), PGE, PGE2, PGD2 Vasoconstriction Thromboxane A2, leukotrienes C4, D4, E4 Increased vascular permeability Leukotrienes C4, D4, E4 Chemotaxis, leukocyte adhesion Leukotrienes B4, HETE HETE, Hydroxyeicosatetraenoic acid.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bf413dcc",
      "audio": ""
    },
    {
      "text": "All of the following leukotrienes cause vasoconstriction except?",
      "options": [
        {
          "label": "A",
          "text": "LTB4",
          "correct": true
        },
        {
          "label": "B",
          "text": "LTC4",
          "correct": false
        },
        {
          "label": "C",
          "text": "LTD4",
          "correct": false
        },
        {
          "label": "D",
          "text": "LTE4",
          "correct": false
        }
      ],
      "correct_answer": "A. LTB4",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>LTB4 LTB 4 is a potent chemotactic agent and activator of neutrophils , causing aggregation and adhesion of the cells to venular endothelium , generation of ROS , and release of lysosomal enzymes . The cysteinyl-containing leukotrienes LTC4, LTD4, and LTE 4 cause intense vasoconstriction, bronchospasm (important in asthma), and increased permeability of venules. table,tr,th,td {border:1px solid black;} Action Eicosanoid Vasodilation Prostaglandins PGI2 (prostacyclin), PGE, PGE2, PGD2 Vasoconstriction Thromboxane A2, leukotrienes C4, D4, E4 Increased vascular permeability Leukotrienes C4, D4, E4 Chemotaxis, leukocyte adhesion Leukotrienes B4, HETE HETE, Hydroxyeicosatetraenoic acid.</p>\n<p><strong>Highyeild:</strong></p><p>Mediator Source Action Histamine Mast cells, basophils, platelets Vasodilation, increased vascular permeability, endothelial activation Prostaglandins Mast cells, leukocytes Vasodilation, pain, fever Leukotrienes Mast cells, leukocytes Increased vascular permeability, chemotaxis, leukocyte adhesion and activation Cytokines (TNF, IL-1, IL-6) Macrophages, endothelial cells, mast cells Local: endothelial activation (expression of adhesion molecules) Systemic: fever, metabolic abnormalities, hypotension (shock) Chemokines Leukocytes, activated macrophages Chemotaxis, leukocyte activation Platelet- activating factor Leukocytes, mast cells Vasodilation, increased vascular permeability, leukocyte adhesion, chemotaxis, degranulation, oxidative burst Complement Plasma (produced in liver) Leukocyte chemotaxis and activation, direct target killing (membrane attack complex), vasodilation (mast cell stimulation) Kinins Plasma (produced in liver Increased vascular permeability, smooth muscle contraction, vasodilation, pain</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Options A, B, C are incorrect</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2ab5135f",
      "audio": ""
    },
    {
      "text": "Which of the following increases platelet aggregation?",
      "options": [
        {
          "label": "A",
          "text": "PGD2",
          "correct": false
        },
        {
          "label": "B",
          "text": "PAGE2",
          "correct": false
        },
        {
          "label": "C",
          "text": "PGI2",
          "correct": false
        },
        {
          "label": "D",
          "text": "TXA2",
          "correct": true
        }
      ],
      "correct_answer": "D. TXA2",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>TXA2 Platelets contain the enzyme thromboxane synthase , and hence TxA2 is the primary product in these cells. TxA2 , a potent platelet-aggregating agent and vasoconstrictor , is unstable and rapidly converted to an inactive form. The vascular endothelium lacks thromboxane synthase but contains prostacyclin synthase , which is responsible for the formation of prostacyclin (PGI2) and its stable end product PGF1a. Prostacyclin is a vasodilator and a potent inhibitor of platelet aggregation and also markedly potentiates the permeability-increasing and chemotactic effects of other mediators. PGD2 is the major prostaglandin made by mast cells ; along with PAGE2 , it causes vasodilation and increases the permeability of postcapillary venules, thus potentiating edema formation . PGD2 also is a chemoattractant for neutrophils .</p>\n<p><strong>Highyeild:</strong></p><p>Mediator Source Action Histamine Mast cells, basophils, platelets Vasodilation, increased vascular permeability, endothelial activation Prostaglandins Mast cells, leukocytes Vasodilation, pain, fever Leukotrienes Mast cells, leukocytes Increased vascular permeability, chemotaxis, leukocyte adhesion and activation Cytokines (TNF, IL-1, IL-6) Macrophages, endothelial cells, mast cells Local: endothelial activation (expression of adhesion molecules) Systemic: fever, metabolic abnormalities, hypotension (shock) Chemokines Leukocytes, activated macrophages Chemotaxis, leukocyte activation Platelet- activating factor Leukocytes, mast cells Vasodilation, increased vascular permeability, leukocyte adhesion, chemotaxis, degranulation, oxidative burst Complement Plasma (produced in liver) Leukocyte chemotaxis and activation, direct target killing (membrane attack complex), vasodilation (mast cell stimulation) Kinins Plasma (produced in liver Increased vascular permeability, smooth muscle contraction, vasodilation, pain</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. PGD2. Increase mucin production . Option: B. PAGE2 Causes vasodilation . Option: C. PGI2. Decrease platelet aggregation .</p>\n<p><strong>Extraedge:</strong></p><p>Role of Arachidonic Acid Metabolites: Table 3.6 Principal Actions of Arachidonic Acid Metabolites in Inflammation Action Eicosanoid Vasodilation Prostaglandins PGI2 (prostacyclin), PGE, PGE2, PGD2 Vasoconstriction Thromboxane A2, leukotrienes C4, D4, E4 Increased vascular permeability Leukotrienes C4, D4, E4 Chemotaxis, leukocyte adhesion Leukotrienes B4, HETE HETE, Hydroxyeicosatetraenoic acid.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c99358e5",
      "audio": ""
    },
    {
      "text": "Which of the following is the main cytokines during the acute inflammatory response?",
      "options": [
        {
          "label": "A",
          "text": "TNF",
          "correct": true
        },
        {
          "label": "B",
          "text": "IFN- gamma",
          "correct": false
        },
        {
          "label": "C",
          "text": "TGF- beta",
          "correct": false
        },
        {
          "label": "D",
          "text": "All of the above",
          "correct": false
        }
      ],
      "correct_answer": "A. TNF",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>TNF TNF and IL-1 serve critical roles in leukocyte recruitment by promoting the adhesion of leukocytes to endothelium and their migration through blood vessels . Microbial products, dead cells, immune complexes, foreign bodies, physical injury, and other inflammatory stimuli can stimulate the secretion of TNF and IL-1.</p>\n<p><strong>Highyeild:</strong></p><p>Cytokine Principal Sources Principal Actions in Inflammation In Acute Inflammation TNF Macrophages, mast cells, T lymphocytes Stimulates expression of endothelial adhesion molecules and secretion of other cytokines; systemic effects IL-I Macrophages, endothelial cells, some epithelial cells Similar to TNF; greater role in fever IL-6 Macrophages, other cells Systemic effects (acute phase response) Chemokines Macrophages, endothelial cells, T lymphocytes, mast cells, other cell types Recruitment of leukocytes to sites of inflammation; migration of cells in normal tissues IL-17 T lymphocytes Recruitment of neutrophils and monocytes In Chronic Inflammation IL-12 Dendritic cells, macrophages Increased production of IFN-y IFN-Y T lymphocytes, NK cells Activation of macrophages (increased ability to kill microbes and tumor cells) IL-17 T lymphocytes Recruitment of neutrophils and monocytes</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B. IFN- gamma. Mostly in chronic Inflammation . Option: C. TGF- beta. Involved in the healing process . Option: D. All of the above. Incorrect .</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8d3fa004",
      "audio": ""
    },
    {
      "text": "Which of the following are the effects of cytokines during inflammation except?",
      "options": [
        {
          "label": "A",
          "text": "Production of acute phase reactants",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fever and cachexia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Stimulate endothelium and macrophages",
          "correct": false
        },
        {
          "label": "D",
          "text": "None of the above",
          "correct": true
        }
      ],
      "correct_answer": "D. None of the above",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>None of the above Cytokines are proteins produced by many cell types (principally activated lymphocytes, macrophages, and dendritic cells, but also endothelial, epithelial, and connective tissue cells) that mediate and regulate immune and inflammatory reactions .</p>\n<p><strong>Highyeild:</strong></p><p>Cytokine Principal Sources Principal Actions in Inflammation In Acute Inflammation TNF Macrophages, mast cells, T lymphocytes Stimulates expression of endothelial adhesion molecules and secretion of other cytokines; systemic effects IL-I Macrophages, endothelial cells, some epithelial cells Similar to TNF; greater role in fever IL-6 Macrophages, other cells Systemic effects (acute phase response) Chemokines Macrophages, endothelial cells, T lymphocytes, mast cells, other cell types Recruitment of leukocytes to sites of inflammation; migration of cells in normal tissues IL-17 T lymphocytes Recruitment of neutrophils and monocytes In Chronic Inflammation IL-12 Dendritic cells, macrophages Increased production of IFN-y IFN-Y T lymphocytes, NK cells Activation of macrophages (increased ability to kill microbes and tumor cells) IL-17 T lymphocytes Recruitment of neutrophils and monocytes</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Production of acute phase reactants. The function of cytokine . Option: B. Fever and cachexia. The function of cytokine . Option: C. Stimulate endothelium and macrophages. The function of cytokine .</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0a588db7",
      "audio": ""
    },
    {
      "text": "Which of the following decreases during inflammation?",
      "options": [
        {
          "label": "A",
          "text": "Fibrinogen",
          "correct": false
        },
        {
          "label": "B",
          "text": "Albumin",
          "correct": true
        },
        {
          "label": "C",
          "text": "CRP",
          "correct": false
        },
        {
          "label": "D",
          "text": "SAA",
          "correct": false
        }
      ],
      "correct_answer": "B. Albumin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Albumin Negative Acute Phase Reactants decrease during inflammation. Albumin and transferrin are negative acute-phase reactants Elevated levels of acute-phase proteins (APR) , which are plasma proteins mostly synthesised in the liver , whose plasma concentrations may increase several hundred\u2013fold as part of the response to inflammatory stimuli.</p>\n<p><strong>Highyeild:</strong></p><p>Acute Phase Reactants: Positive Acute Phase Reactants Negative Acute Phase Reactants Fibrinogen Transferrin CRP Albumin Ferritin Transthyretin Haptoglobin Hepcidin Ceruloplasmin Serum amyloid (SAA)</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Fibrinogen. Positive APR . Option: C. CRP. Positive APR . Option: D. SAA. Positive APR .</p>\n<p><strong>Extraedge:</strong></p><p>Elevated serum levels of CRP have been proposed as a marker for increased risk of myocardial infarction in patients with coronary artery disease. It is postulated that inflammation involving atherosclerotic plaques in the coronary arteries may predispose to thrombosis and subsequent infarction. Hepcidin is a small protein that reduces iron availability to erythroid progenitors in the bone marrow; over time, this effect may lead to anemia or chronic inflammation . Thrombopoietin , the major growth factor for megakaryocytes (platelet precursors) in the bone marrow, is also upregulated. As a result, systemic inflammation may be associated with an elevated platelet count ( thrombocytosis ). Acute-phase proteins have beneficial effects during acute inflammation, but prolonged production of these proteins (especially SAA ) in states of chronic inflammation causes secondary amyloidosis .</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "de817e2b",
      "audio": ""
    },
    {
      "text": "All of the following are positive acute phase reactants except?",
      "options": [
        {
          "label": "A",
          "text": "Transferrin",
          "correct": true
        },
        {
          "label": "B",
          "text": "Haptoglobin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ferritin",
          "correct": false
        },
        {
          "label": "D",
          "text": "None of the above",
          "correct": false
        }
      ],
      "correct_answer": "A. Transferrin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Transferrin It is a negative acute phase reactant .</p>\n<p><strong>Highyeild:</strong></p><p>Acute Phase Reactants: Positive Acute Phase Reactants Negative Acute Phase Reactants Fibrinogen Transferrin CRP Albumin Ferritin Transthyretin Haptoglobin Hepcidin Ceruloplasmin Serum amyloid (SAA) </table</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B. Haptoglobin. Positive APR . Option: C. Ferritin. Positive APR . Option: D. None. Incorrect .</p>\n<p><strong>Extraedge:</strong></p><p>Elevated serum levels of CRP have been proposed as a marker for increased risk of myocardial infarction in patients with coronary artery disease. It is postulated that inflammation involving atherosclerotic plaques in the coronary arteries may predispose to thrombosis and subsequent infarction. Hepcidin is a small protein that reduces the availability of iron to erythroid progenitors in the bone marrow; over time, this effect may lead to anemia or chronic inflammation . Thrombopoietin , the major growth factor for megakaryocytes (platelet precursors) in the bone marrow, is also upregulated and as a result systemic inflammation may be associated with an elevated platelet count ( thrombocytosis ). Acute-phase proteins have beneficial effects during acute inflammation, but prolonged production of these proteins (especially SAA ) in states of chronic inflammation causes secondary amyloidosis .</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2a54df3f",
      "audio": ""
    },
    {
      "text": "Which one of the following is a function of PGI2?",
      "options": [
        {
          "label": "A",
          "text": "Vasoconstriction and inhibits platelet aggregation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Vasodilator and inhibits platelet aggregation",
          "correct": true
        },
        {
          "label": "C",
          "text": "Vasoconstriction and increases platelet aggregation",
          "correct": false
        },
        {
          "label": "D",
          "text": "Vasodilator and increases platelet aggregation",
          "correct": false
        }
      ],
      "correct_answer": "B. Vasodilator and inhibits platelet aggregation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Vasodilator and inhibits platelet aggregation Platelets contain the enzyme thromboxane synthase , and hence TxA2 is the major product in these cells. TxA2 , a potent platelet-aggregating agent and vasoconstrictor , is itself unstable and rapidly converted to its inactive form. The vascular endothelium lacks thromboxane synthase but contains prostacyclin synthase , which is responsible for the formation of prostacyclin (PGI2) and its stable end product PGF1a. Prostacyclin is a vasodilator and a potent inhibitor of platelet aggregation , and also markedly potentiates the permeability-increasing and chemotactic effects of other mediators. PGD2 is the major prostaglandin made by mast cells ; along with PAGE2 , it causes vasodilation and increases the permeability of postcapillary venules, thus potentiating edema formation . PGD2 also is a chemoattractant for neutrophils .</p>\n<p><strong>Highyeild:</strong></p><p>Mediator Source Action Histamine Mast cells, basophils, platelets Vasodilation, increased vascular permeability, endothelial activation Prostaglandins Mast cells, leukocytes Vasodilation, pain, fever Leukotrienes Mast cells, leukocytes Increased vascular permeability, chemotaxis, leukocyte adhesion and activation Cytokines (TNF, IL-1, IL-6) Macrophages, endothelial cells, mast cells Local: endothelial activation (expression of adhesion molecules) Systemic: fever, metabolic abnormalities, hypotension (shock) Chemokines Leukocytes, activated macrophages Chemotaxis, leukocyte activation Platelet- activating factor Leukocytes, mast cells Vasodilation, increased vascular permeability, leukocyte adhesion, chemotaxis, degranulation, oxidative burst Complement Plasma (produced in liver) Leukocyte chemotaxis and activation, direct target killing (membrane attack complex), vasodilation (mast cell stimulation) Kinins Plasma (produced in liver Increased vascular permeability, smooth muscle contraction, vasodilation, pain</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Vasoconstriction and inhibits platelet aggregation. Incorrect . Option: B. Vasoconstriction and increases platelet aggregation. Incorrect . Option: C. Vasodilator and increases platelet aggregation. Incorrect .</p>\n<p><strong>Extraedge:</strong></p><p>Role of Arachidonic Acid Metabolites Table 3.6 Principal Actions of Arachidonic Acid Metabolites in Inflammation Action Eicosanoid Vasodilation Prostaglandins PGI2 (prostacyclin), PGE, PGE2, PGD2 Vasoconstriction Thromboxane A2, leukotrienes C4, D4, E4 Increased vascular permeability Leukotrienes C4, D4, E4 Chemotaxis, leukocyte adhesion Leukotrienes B4, HETE HETE, Hydroxyeicosatetraenoic acid. Prostaglandins in platelet homeostasis Thromboxane A2 is produced by COX-1 in activated platelets It promotes adherence and aggregation of circulating platelets along with vascular smooth muscle contraction, therefore promoting blood clot (thrombi) formation Prostacyclin (PGI) is produced by COX-2 in vascular endothelial cells It inhibits platelet aggregation and stimulates vasodilation, and thus, slows down thrombogenesis The opposing effects if Thromboxane A2 and Prostacyclin limits the formation of thrombi to sites of vascular injury Aspirin Has an antithrombogenic effect.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1d83ce9d",
      "audio": ""
    },
    {
      "text": "Prostaglandin causing fever is-",
      "options": [
        {
          "label": "A",
          "text": "PGF2",
          "correct": false
        },
        {
          "label": "B",
          "text": "PGE2",
          "correct": true
        },
        {
          "label": "C",
          "text": "PGE1",
          "correct": false
        },
        {
          "label": "D",
          "text": "PGT2",
          "correct": false
        }
      ],
      "correct_answer": "B. PGE2",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>PGE2 Pyrogen s : Substances that cause fever. PGE 2 is hyperalgesic , making the skin hypersensitive to painful stimuli such as intradermal injection of suboptimal concentrations of histamine and bradykinin. It is involved in cytokine-induced fever during infections . In the hypothalamus , the prostaglandins, especially PGE2 , stimulate the production of neurotransmitters that reset the temperature set point at a higher level .</p>\n<p><strong>Highyeild:</strong></p><p>Mediator Source Action Histamine Mast cells, basophils, platelets Vasodilation, increased vascular permeability, endothelial activation Prostaglandins Mast cells, leukocytes Vasodilation, pain, fever Leukotrienes Mast cells, leukocytes Increased vascular permeability, chemotaxis, leukocyte adhesion and activation Cytokines (TNF, IL-1, IL-6) Macrophages, endothelial cells, mast cells Local: endothelial activation (expression of adhesion molecules) Systemic: fever, metabolic abnormalities, hypotension (shock) Chemokines Leukocytes, activated macrophages Chemotaxis, leukocyte activation Platelet- activating factor Leukocytes, mast cells Vasodilation, increased vascular permeability, leukocyte adhesion, chemotaxis, degranulation, oxidative burst Complement Plasma (produced in liver) Leukocyte chemotaxis and activation, direct target killing (membrane attack complex), vasodilation (mast cell stimulation) Kinins Plasma (produced in liver Increased vascular permeability, smooth muscle contraction, vasodilation, pain</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Options A, C, D are incorrect</p>\n<p><strong>Extraedge:</strong></p><p>Role of Arachidonic Acid Metabolites: Action Eicosanoid Vasodilation Prostaglandins PGI2 (prostacyclin), PGE, PGE2, PGD2 Vasoconstriction Thromboxane A2, leukotrienes C4, D4, E4 Increased vascular permeability Leukotrienes C4, D4, E4 Chemotaxis, leukocyte adhesion Leukotrienes B4, HETE HETE, Hydroxyeicosatetraenoic acid.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0db15f9b",
      "audio": ""
    },
    {
      "text": "All of the following are true regarding about Arachidonic acid (AA) pathway, except:",
      "options": [
        {
          "label": "A",
          "text": "Aspirin inhibits the arachidonic acid pathway",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cytosolic Calcium leads to activation of membrane phospholipase A2",
          "correct": false
        },
        {
          "label": "C",
          "text": "Action of phospholipase A2 causes synthesis of arachidonic acid",
          "correct": false
        },
        {
          "label": "D",
          "text": "Leukotrienes C4, D4 cause vasodilation",
          "correct": true
        }
      ],
      "correct_answer": "D. Leukotrienes C4, D4 cause vasodilation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Leukotrienes C4, D4 cause vasodilation The lipid mediators prostaglandins and leukotrienes are produced from arachidonic acid (AA) present in membrane phospholipids and stimulate vascular and cellular reactions in acute inflammation. AA is a 20-carbon polyunsaturated fatty acid (5,8,11,14-eicosatetraenoic acid) that is derived from dietary sources or by synthesis from a precursor molecule, the essential fatty acid linoleic acid Cellular phospholipases, mainly phospholipase A2 , release AA from membrane phospholipids . Activation of phospholipase A2 is triggered by an increase in cytosolic Calcium Leukotrienes are produced in leukocytes and mast cells by the action of lipoxygenase. Leukotrienes are more potent than histamine in increasing vascular permeability and causing bronchospasm . Cyclo-oxygenase inhibitors such as Aspirin, Indomethacin inhibit the activity of cyclooxygenase involved in the conversion of AA into prostaglandins . Leukotriene A4, B4 cause chemotaxis. Leukotrienes C4 and D4 cause vasoconstriction and increase vascular permeability.</p>\n<p><strong>Highyeild:</strong></p><p>Mediator Source Action Histamine Mast cells, basophils, platelets Vasodilation, increased vascular permeability, endothelial activation Prostaglandins Mast cells, leukocytes Vasodilation, pain, fever Leukotrienes Mast cells, leukocytes Increased vascular permeability, chemotaxis, leukocyte adhesion and activation Cytokines (TNF, IL-1, IL-6) Macrophages, endothelial cells, mast cells Local: endothelial activation (expression of adhesion molecules) Systemic: fever, metabolic abnormalities, hypotension (shock) Chemokines Leukocytes, activated macrophages Chemotaxis, leukocyte activation Platelet- activating factor Leukocytes, mast cells Vasodilation, increased vascular permeability, leukocyte adhesion, chemotaxis, degranulation, oxidative burst Complement Plasma (produced in liver) Leukocyte chemotaxis and activation, direct target killing (membrane attack complex), vasodilation (mast cell stimulation) Kinins Plasma (produced in liver Increased vascular permeability, smooth muscle contraction, vasodilation, pain</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Aspirin inhibits the arachidonic acid pathway. Correct . Option: B. Cytosolic Calcium leads to the activation of membrane phospholipase A2. Correct . Option: C. Action of phospholipase A2 causes synthesis of arachidonic acid. Correct .</p>\n<p><strong>Extraedge:</strong></p><p>Role of Arachidonic Acid Metabolites: Action Eicosanoid Vasodilation Prostaglandins PGI2 (prostacyclin), PGE, PGE2, PGD2 Vasoconstriction Thromboxane A2, leukotrienes C4, D4, E4 Increased vascular permeability Leukotrienes C4, D4, E4 Chemotaxis, leukocyte adhesion Leukotrienes B4, HETE HETE, Hydroxyeicosatetraenoic acid.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1dfc01a4",
      "audio": ""
    },
    {
      "text": "All of the following are mediators of inflammation, except",
      "options": [
        {
          "label": "A",
          "text": "Tumour necrosis factor-\u03b1 (TNF-\u03b1)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Interleukin-1",
          "correct": false
        },
        {
          "label": "C",
          "text": "Myeloperoxidase",
          "correct": true
        },
        {
          "label": "D",
          "text": "Prostaglandins",
          "correct": false
        }
      ],
      "correct_answer": "C. Myeloperoxidase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Myeloperoxidase Inflammatory mediators are the substances that initiate and regulate inflammatory reactions . The most important mediators of acute inflammation are vasoactive amines, lipid products ( prostaglandins and leukotrienes ), cytokines (including chemokines ), and products of complement activation . Myeloperoxidase (MPO) is an enzyme present in primary (or azurophilic) granules of the neutrophils and takes part in the formation of reactive oxygen species .</p>\n<p><strong>Highyeild:</strong></p><p>Mediator Source Action Histamine Mast cells, basophils, platelets Vasodilation, increased vascular permeability, endothelial activation Prostaglandins Mast cells, leukocytes Vasodilation, pain, fever Leukotrienes Mast cells, leukocytes Increased vascular permeability, chemotaxis, leukocyte adhesion and activation Cytokines (TNF, IL-1, IL-6) Macrophages, endothelial cells, mast cells Local: endothelial activation (expression of adhesion molecules) Systemic: fever, metabolic abnormalities, hypotension (shock) Chemokines Leukocytes, activated macrophages Chemotaxis, leukocyte activation Platelet- activating factor Leukocytes, mast cells Vasodilation, increased vascular permeability, leukocyte adhesion, chemotaxis, degranulation, oxidative burst Complement Plasma (produced in liver) Leukocyte chemotaxis and activation, direct target killing (membrane attack complex), vasodilation (mast cell stimulation) Kinins Plasma (produced in liver Increased vascular permeability, smooth muscle contraction, vasodilation, pain</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Tumour necrosis factor-\u03b1 (TNF-\u03b1). Inflammatory mediator . Option: B. Interleukin-1. Inflammatory mediator . Option: C. Prostaglandins. Inflammatory mediator .</p>\n<p><strong>Extraedge:</strong></p><p>Role of Arachidonic Acid Metabolites: Action Eicosanoid Vasodilation Prostaglandins PGI2 (prostacyclin), PGE, PGE2, PGD2 Vasoconstriction Thromboxane A2, leukotrienes C4, D4, E4 Increased vascular permeability Leukotrienes C4, D4, E4 Chemotaxis, leukocyte adhesion Leukotrienes B4, HETE HETE, Hydroxyeicosatetraenoic acid.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4f4ba9d0",
      "audio": ""
    },
    {
      "text": "Vitamin K leads to:",
      "options": [
        {
          "label": "A",
          "text": "Gamma carboxylation of aspartic acid residues to clotting factor 2,7, 9 and 10",
          "correct": false
        },
        {
          "label": "B",
          "text": "Beta-carboxylation of glutamic acid residues to clotting factor 2,7, 9 and 10",
          "correct": false
        },
        {
          "label": "C",
          "text": "Alpha-carboxylation of aspartic acid residues to clotting factor 2,7, 9 and 10",
          "correct": false
        },
        {
          "label": "D",
          "text": "Gamma carboxylation of glutamic acid residues to clotting factor 2,7, 9 and 10",
          "correct": true
        }
      ],
      "correct_answer": "D. Gamma carboxylation of glutamic acid residues to clotting factor 2,7, 9 and 10",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Gamma carboxylation of glutamic acid residues to clotting factor 2,7, 9 and 10 Vi tamin K is synthesised by gut flora . Deficiency is more commonly seen in neonate s . Act as Cofactor in hepatic carboxylation of procoagulants-factors ll(prothrombin), VIl , IX , and X ; and protein C and protein S . Warfarin inhibits epoxide reductase , thus inhibiting the activity of vitamin K enzymatic reactions that produce \u03b3-carboxylated glutamic acid that use Vitamin K as a cofactor and are antagonised by drugs such as Warfarin (Coumadin), a widely used anticoagulant.</p>\n<p><strong>Highyeild:</strong></p><p>Vitamin Functions Deficiency Syndromes Fat-Soluble Vitamin A A component of visual pigment Maintenance of specialized epithelia Maintenance of resistance to infection Night blindness, xerophthalmia, blindness Squamous metaplasia Vulnerability to infection, particularly measles Vitamin D Facilitates intestinal absorption of calcium and phosphorus and mineralization of bone Rickets in children Osteomalacia in adults Vitamin E Major antioxidant; scavenges free radicals Spinocerebellar degeneration, hemolytic anemia Vitamin K Cofactor in hepatic carboxylation of procoagulants-factors Il (prothrombin), VII, IX, and X and protein C and protein S Bleeding diathesis (Chapter 14) Water-Soluble Vitamin B, (thiamine) As pyrophosphate, is coenzyme in decarboxylation reactions Dry and wet beriberi, Wernicke syndrome, Korsakoff syndrome (Chapter 28) Vitamin B2 (riboflavin) Converted to coenzymes flavin mononucleotide and flavin adenine dinucleotide, cofactors for many enzymes in intermediary metabolism Ariboflavinosis, cheilosis, stomatitis, glossitis, dermatitis, corneal vascularization Niacin Incorporated into nicotinamide adenine dinucleotide (NAD) and NAD phosphate, involved in a variety of redox reactions Pellagra \"three Ds\": dementia, dermatitis, diarrhea Vitamin B6 (pyridoxine) Derivatives serve as coenzymes in many intermediary reactions Cheilosis, glossitis, dermatitis, peripheral neuropathy (Chapter 28) Maintenance of myelinization of spinal cord tracts Vitamin B2 Required for normal folate metabolism and DNA synthesis Megaloblastic pernicious anemia and degeneration of posterolateral spinal cord tracts (Chapter 14) Vitamin C Serves in many oxidation-reduction (redox) reactions and hydroxylation of collagen Scurvy Folate Essential for transfer and use of one-carbon units in DNA synthesis Megaloblastic anemia, neural tube defects (Chapter 14) Pantothenic acid Incorporated in coenzyme A No nonexperimental syndrome recognized Biotin Cofactor in carboxylation reactions No clearly defined clinical syndrome</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Gamma carboxylation of aspartic acid residues to clotting factors 2,7, 9 and 10. Incorrect . Option: B. Beta-carboxylation of glutamic acid residues to clotting factors 2,7, 9 and 10. Incorrect . Option: C. Alpha-carboxylation of aspartic acid residues to clotting factors 2,7, 9 and 10. Incorrect .</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1538fe83",
      "audio": ""
    },
    {
      "text": "Activated protein C inhibit clotting mechanism by inactivating which of the following clotting factors:",
      "options": [
        {
          "label": "A",
          "text": "Factor Illa and Factor VIlla",
          "correct": false
        },
        {
          "label": "B",
          "text": "Factor VIIla and Factor IXa",
          "correct": false
        },
        {
          "label": "C",
          "text": "Factor Va and Factor VIlla",
          "correct": true
        },
        {
          "label": "D",
          "text": "Factor Va and Factor Vlla",
          "correct": false
        }
      ],
      "correct_answer": "C. Factor Va and Factor VIlla",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Factor Va and Factor VIlla Protein-C is a vitamin K-dependent protease that requires a cofactor (Protein S) . Activated Protein C/protein S forms a complex that is a potent inhibitor of coagulation factors Va and Factor VIlla . Protein C acts as a Tissue factor pathway inhibitor (TFPI)</p>\n<p><strong>Highyeild:</strong></p><p>Primary (Genetic) Common Factor V mutation: factor V Leiden (Arg to Gln substitution in amino acid residue 506 leading to resistance to activated protein C) Prothrombin mutation (G20210A noncoding sequence variant leading to increased prothrombin levels) Increased levels of factors VIII, IX, XI, or fibrinogen (genetics unknown) Rare Antithrombin III deficiency Protein C deficiency Protein S deficiency Very Rare Fibrinolysis defects Homozygous homocystinuria (deficiency of cystathione B-synthetase) Secondary (Acquired) Strong Risk Factors for Thrombosis Prolonged bed rest or immobilization Myocardial infarction Atrial fibrillation Tissue injury (surgery, fracture, burn) Cancer Prosthetic cardiac valves Disseminated intravascular coagulation Heparin-induced thrombocytopenia Antiphospholipid antibody syndrome Other Risk Factors for Thrombosis Cardiomyopathy Nephrotic syndrome Hyperestrogenic states (pregnancy and postpartum) Oral contraceptive use Sickle cell anemia Smoking</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Factor Illa and Factor VIlla. Incorrect . Option: B. Factor VIIla and Factor IXa. Incorrect . Option: D. Factor Va and Factor Vlla. Incorrect .</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fa6b91cd",
      "audio": ""
    },
    {
      "text": "An 80-year-old woman presents with a 4-hour history of fever, shaking chills and disorientation. Her blood pressure is 80/40 mm Hg. Physical Examination shows diffuse purpura on her upper arms and chest. Blood Cultures are positive for Gram-negative organisms. Which of the following cytokines is primarily involved in the pathogenesis of direct vascular injury in this patient with septic shock?",
      "options": [
        {
          "label": "A",
          "text": "Interferon-\u03b3",
          "correct": false
        },
        {
          "label": "B",
          "text": "Transforming Growth Factor-\u03b2 (TGF-\u03b2)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Platelet-derived growth factor",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tumor necrosis factor-\u03b1",
          "correct": true
        }
      ],
      "correct_answer": "D. Tumor necrosis factor-\u03b1",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Tumor necrosis factor-\u03b1 Septicemia (bacteremia) denotes the clinical condition in which bacteria are found in the circulation . It can be suspected clinically, but the final diagnosis is made by culturing the organisms from the blood. In sepsis, the large amounts of bacteria and their products in the blood stimulate the production of enormous quantities of several cytokines, notably TNF and IL-1 . High blood levels of cytokines cause various clinical manifestations, such as disseminated intravascular coagulation, hypotensive shock, and metabolic disturbances, including insulin resistance and hyperglycemia . This clinical triad is known as septic shock and is one form of a severe, often fatal disorder referred to as systemic inflammatory response syndrome . In patients with endotoxic shock , lipopolysaccharide released from Gram-negative bacteria stimulates monocytes/macrophages to secrete large quantities of TNF- \u03b1 .</p>\n<p><strong>Highyeild:</strong></p><p>Mediator Source Action Histamine Mast cells, basophils, platelets Vasodilation, increased vascular permeability, endothelial activation Prostaglandins Mast cells, leukocytes Vasodilation, pain, fever Leukotrienes Mast cells, leukocytes Increased vascular permeability, chemotaxis, leukocyte adhesion and activation Cytokines (TNF, IL-1, IL-6) Macrophages, endothelial cells, mast cells Local: endothelial activation (expression of adhesion molecules) Systemic: fever, metabolic abnormalities, hypotension (shock) Chemokines Leukocytes, activated macrophages Chemotaxis, leukocyte activation Platelet- activating factor Leukocytes, mast cells Vasodilation, increased vascular permeability, leukocyte adhesion, chemotaxis, degranulation, oxidative burst Complement Plasma (produced in liver) Leukocyte chemotaxis and activation, direct target killing (membrane attack complex), vasodilation (mast cell stimulation) Kinins Plasma (produced in liver Increased vascular permeability, smooth muscle contraction, vasodilation, pain</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Interferon-\u03b3. NK cells and T cells secrete cytokines such as interferon-\u03b3 ( IFN-\u03b3 ), which activate macrophages to destroy ingested microbes and even tumor cells . Option: B. Transforming Growth Factor-\u03b2 (TGF-\u03b2). Antiinflammatory cytokines, like transforming growth factor-\u03b2 ( TGF-\u03b2 ) and IL-10, are released from macrophages and help in tissue repair and fibrosis . Option: C. Platelet-derived growth factor. The growth factors platelet-derived growth factor ( PDGF ) results in increased synthesis of extracellular matrix and cause fibrosis .</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "581f49a7",
      "audio": ""
    },
    {
      "text": "A 25-year-old woman developed a sore, red, hot, swollen left knee. She has no history of trauma and no family history of joint disease. Aspirin effectively relieves symptoms of acute inflammation in this patient because it inhibits which of the following enzymes?",
      "options": [
        {
          "label": "A",
          "text": "Cyclooxygenase",
          "correct": true
        },
        {
          "label": "B",
          "text": "Lipoxygenase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Phospholipase A2",
          "correct": false
        },
        {
          "label": "D",
          "text": "Superoxide dismutase",
          "correct": false
        }
      ],
      "correct_answer": "A. Cyclooxygenase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Cyclooxygenase The lipid mediators prostaglandins and leukotrienes are produced from arachidonic acid (AA) in membrane phospholipids. Cellular phospholipases, mainly phospholipase A2 , release AA from membrane phospholipids . An increase in cytosolic Calcium triggers the activation of phospholipase A2 . Leukotrienes are produced in leukocytes and mast cells by lipoxygenase. Leukotrienes are more potent than histamine in increasing vascular permeability and causing bronchospasm . Cyclo-oxygenase inhibitors such as Aspirin, Indomethacin inhibit the activity of cyclooxygenase involved in the conversion of AA into prostaglandins , exerting their potent analgesic and anti-inflammatory effects . Leukotriene A4, B4 cause chemotaxis. Leukotrienes C4 and D4 cause vasoconstriction and increase vascular permeability.</p>\n<p><strong>Highyeild:</strong></p><p>Mediator Source Action Histamine Mast cells, basophils, platelets Vasodilation, increased vascular permeability, endothelial activation Prostaglandins Mast cells, leukocytes Vasodilation, pain, fever Leukotrienes Mast cells, leukocytes Increased vascular permeability, chemotaxis, leukocyte adhesion and activation Cytokines (TNF, IL-1, IL-6) Macrophages, endothelial cells, mast cells Local: endothelial activation (expression of adhesion molecules) Systemic: fever, metabolic abnormalities, hypotension (shock) Chemokines Leukocytes, activated macrophages Chemotaxis, leukocyte activation Platelet- activating factor Leukocytes, mast cells Vasodilation, increased vascular permeability, leukocyte adhesion, chemotaxis, degranulation, oxidative burst Complement Plasma (produced in liver) Leukocyte chemotaxis and activation, direct target killing (membrane attack complex), vasodilation (mast cell stimulation) Kinins Plasma (produced in liver Increased vascular permeability, smooth muscle contraction, vasodilation, pain</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Lipoxygenase. Inhibited by Zileuton . Option: B. Phospholipase A2. Inhibited by steroids . Option: C. Superoxide dismutase. Incorrect .</p>\n<p><strong>Extraedge:</strong></p><p>Role of Arachidonic Acid Metabolites: Action Eicosanoid Vasodilation Prostaglandins PGI2 (prostacyclin), PGE, PGE2, PGD2 Vasoconstriction Thromboxane A2, leukotrienes C4, D4, E4 Increased vascular permeability Leukotrienes C4, D4, E4 Chemotaxis, leukocyte adhesion Leukotrienes B4, HETE HETE, Hydroxyeicosatetraenoic acid.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "335557bc",
      "audio": ""
    },
    {
      "text": "A 59-year-old man experiences acute chest pain and is rushed to the emergency room. Laboratory studies and ECG demonstrate an acute myocardial infarction; however, coronary artery angiography performed 2 hours later does not show evidence of thrombosis. Which of the following mediators of inflammation causes relaxation of vascular smooth muscle cells and vasodilation of arterioles at the site of myocardial infarction in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Bradykinin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Histamine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Leukotrienes",
          "correct": false
        },
        {
          "label": "D",
          "text": "Nitric oxide",
          "correct": true
        }
      ],
      "correct_answer": "D. Nitric oxide",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Nitric oxide Nitric oxide (NO) , previously known as an endothelium-derived relaxing factor , leads to the relaxation of vascular smooth muscle cells and vasodilation of arterioles . NO also inhibits platelet aggregation and mediates the killing of bacteria and tumor cells by macrophages. Histamine, leukotrienes and thromboxane A2 stimulate the contraction of smooth muscle cells. NO , a soluble gas produced from arginine by the action of nitric oxide synthase (NOS)</p>\n<p><strong>Highyeild:</strong></p><p>NO is synthesised from Arginine . Sites: Endothelium (eNO): Maintains vascular tone Nerves (nNO): Neurotransmitter Inducible (iNO): Inflammation Functions: Vasodilation Smooth muscle relaxation Reactive Oxygen Species table,tr,th,td {border:1px solid black;} Mediator Source Action Histamine Mast cells, basophils, platelets Vasodilation, increased vascular permeability, endothelial activation Prostaglandins Mast cells, leukocytes Vasodilation, pain, fever Leukotrienes Mast cells, leukocytes Increased vascular permeability, chemotaxis, leukocyte adhesion and activation Cytokines (TNF, IL-1, IL-6) Macrophages, endothelial cells, mast cells Local: endothelial activation (expression of adhesion molecules) Systemic: fever, metabolic abnormalities, hypotension (shock) Chemokines Leukocytes, activated macrophages Chemotaxis, leukocyte activation Platelet- activating factor Leukocytes, mast cells Vasodilation, increased vascular permeability, leukocyte adhesion, chemotaxis, degranulation, oxidative burst Complement Plasma (produced in liver) Leukocyte chemotaxis and activation, direct target killing (membrane attack complex), vasodilation (mast cell stimulation) Kinins Plasma (produced in liver Increased vascular permeability, smooth muscle contraction, vasodilation, pain</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Bradykinin increases vascular permeability and causes the contraction of smooth muscle . Option: B. Histamine causes intense smooth muscle contraction, increases vascular permeability, and stimulates mucus secretion by nasal, bronchial, and gastric glands. Option: C. Leukotrienes. Cause bronchospasm and increases vascular permeability .</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f7fb3386",
      "audio": ""
    },
    {
      "text": "Rolling of leukocytes on endothelial cells is mediated by which of the following proteins?",
      "options": [
        {
          "label": "A",
          "text": "Selectins",
          "correct": true
        },
        {
          "label": "B",
          "text": "Integrins",
          "correct": false
        },
        {
          "label": "C",
          "text": "Transferrin",
          "correct": false
        },
        {
          "label": "D",
          "text": "PECAM-1",
          "correct": false
        }
      ],
      "correct_answer": "A. Selectins",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Selectins Rolling interactions of leukocytes are mediated by a family of proteins called selectins . 3 types of selectins: L - selectins (on leukocytes) E - selectin (on endothelium) P - selectin (on platelets, endothelium)</p>\n<p><strong>Highyeild:</strong></p><p>Cellular events of inflammation: Margination: WBC movement inside the lumen of a blood vessel. Occurs due to selectins . Rolling: WBC movement inside the lumen of a blood vessel. Occurs due to selectins (endothelium) and Sialyl Lewis X glycoprotein (WBC) . Adhesion: WBC movement inside the lumen of a blood vessel. Occurs due to ICAM and VCAM (endothelium) and \u03b22 Integrins (WBC) . Diapedesis: WBC moves across the Occurs due to PECAM-1, aka CD31 . Chemotaxis: Movement of WBC along a chemical gradient.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: B. Integrins: Firm adhesion of leukocytes to the endothelial cells is mediated by a family of leucocyte surface proteins called integrins. Option: C. Transferrin: Iron transporting protein . Option: D. PECAM-1: PECAM-1 (platelet endothelium cell adhesion molecule) is present in the intercellular junction between endothelial cells and helps in the migration of leucocytes .</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3b7924b1",
      "audio": ""
    },
    {
      "text": "C3 complement is cleared by?",
      "options": [
        {
          "label": "A",
          "text": "CD 59",
          "correct": false
        },
        {
          "label": "B",
          "text": "CD 55",
          "correct": true
        },
        {
          "label": "C",
          "text": "Factor D",
          "correct": false
        },
        {
          "label": "D",
          "text": "Factor E",
          "correct": false
        }
      ],
      "correct_answer": "B. CD 55",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>CD 55 The complement system is a collection of plasma proteins that function mainly in host defence against microbes and in pathologic inflammatory reactions. It functions in both innate and adaptive immunity for defence against microbial pathogens.</p>\n<p><strong>Highyeild:</strong></p><p>The critical step in complement activation is the proteolysis of the third (and most abundant) component, C3 . Cleavage of C3 can occur by one of three pathways: Classical pathway Alternative pathway Lectin pathway The complement system has three main functions: Inflammation Opsonization and phagocytosis Cell lysis The activation of complement is tightly controlled by cell-associated and circulating regulatory proteins . Regulatory proteins can be overwhelmed when large amounts of complement are deposited on host cells and in tissues. The most important of these regulatory proteins are the following: C1 inhibitor: blocks the activation of C1, the first protein of the classical complement pathway. Inherited deficiency of this inhibitor is the cause of hereditary angioedema . Decay accelerating factor (DAF) ie CD55 and MIRL (Membrane Inhibitor of Reactive Lysis) ie CD59 . DAF prevents the formation of C3 convertases , and CD59 inhibits the formation of the membrane attack complex . Acquired deficiency can lead to paroxysmal nocturnal hemoglobinuria (PNH) . Complement Factor H inhibits the alternative pathway by promoting the cleavage and destruction of C3b and the turnover of the C3 convertases . Inherited defects in Factor H cause an atypical form of Hemolytic Uremic Syndrome .</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Options A, C, D are incorrect</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "49611b3f",
      "audio": ""
    },
    {
      "text": "All of the following are true in respect of hereditary angioneurotic edema(HAE), except",
      "options": [
        {
          "label": "A",
          "text": "Deficiency of C1 inhibitor (C1INH)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Urticaria",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pruritus is usually absent",
          "correct": false
        },
        {
          "label": "D",
          "text": "Autosomal recessive disorder",
          "correct": true
        }
      ],
      "correct_answer": "D. Autosomal recessive disorder",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Autosomal recessive disorder Hereditary angioneurotic edema (HAE): It is caused by an inherited deficiency of C1 esterase inhibitor that results in excessive activation of the early components of the complement system and production of vasoactive mediators . It is an autosomal dominant Although the exact nature of the bioactive compound produced in hereditary angioedema is uncertain, these patients have episodes of edema affecting skin and mucosal surfaces such as the larynx and the gastrointestinal tract . This may result in life- threatening asphyxia or nausea, vomiting, and diarrhea after minor trauma or emotional stress . Acute attacks of hereditary angioedema can be treated with C1 inhibitor concentrates prepared from human plasma . Angioneurotic edema is classically non-pitting in nature . Urticaria(hives) may develop simultaneously, pruritus is not present .</p>\n<p><strong>Highyeild:</strong></p><p>The critical step in complement activation is the proteolysis of the third (and most abundant) component, C3 . Cleavage of C3 can occur by one of three pathways: Classical pathway Alternative pathway Lectin pathway The complement system has three main functions: Inflammation Opsonization and phagocytosis Cell lysis The activation of complement is tightly controlled by cell-associated and circulating regulatory proteins . Regulatory proteins can be overwhelmed when large amounts of complement are deposited on host cells and in tissues. The most important of these regulatory proteins are the following: C1 inhibitor: blocks the activation of C1, the first protein of the classical complement pathway. Inherited deficiency of this inhibitor is the cause of hereditary angioedema . Decay accelerating factor (DAF) ie CD55 and MIRL (Membrane Inhibitor of Reactive Lysis) ie CD59 . DAF prevents the formation of C3 convertases , and CD59 inhibits the formation of the membrane attack complex . Acquired deficiency can lead to paroxysmal nocturnal hemoglobinuria (PNH) . Complement Factor H inhibits the alternative pathway by promoting the cleavage and destruction of C3b and the turnover of the C3 convertases . Inherited defects in Factor H cause an atypical form of Hemolytic Uremic Syndrome .</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Deficiency of C1 inhibitor (C1INH). True . Option: B. Urticaria. True . Option: C. Pruritus is usually absent. True .</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "30092403",
      "audio": ""
    },
    {
      "text": "Deficiency of complement proteins C5to C8 leads to increased infection by which of the following?",
      "options": [
        {
          "label": "A",
          "text": "Streptococcus",
          "correct": false
        },
        {
          "label": "B",
          "text": "Neisseria",
          "correct": true
        },
        {
          "label": "C",
          "text": "Pseudomonas",
          "correct": false
        },
        {
          "label": "D",
          "text": "Staphylococcus",
          "correct": false
        }
      ],
      "correct_answer": "B. Neisseria",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Neisseria The terminal components of complement C5, 6, 7,8, and 9 are required to assemble the membrane attack complex (MAC) involved in the lysis of organisms . The deposition of the membrane attack complex on cells makes these cells permeable to water and ions and results in osmotic lysis of the cells . This role of complement is particularly important for killing microbes with thin cell walls , such as Neisseria , and deficiency of the terminal components of complement (except c9) predisposes Neisseria infections (gonococcal and meningococcal) .</p>\n<p><strong>Highyeild:</strong></p><p>The critical step in complement activation is the proteolysis of the third (and most abundant) component, C3 . Cleavage of C3 can occur by one of three pathways: Classical pathway Alternative pathway Lectin pathway The complement system has three main functions: Inflammation Opsonization and phagocytosis Cell lysis The activation of complement is tightly controlled by cell-associated and circulating regulatory proteins . Regulatory proteins can be overwhelmed when large amounts of complement are deposited on host cells and tissues. The most important of these regulatory proteins are the following: C1 inhibitor: blocks the activation of C1, the first protein of the classical complement pathway. Inherited deficiency of this inhibitor is the cause of hereditary angioedema . Decay accelerating factor (DAF) ie CD55 and MIRL (Membrane Inhibitor of Reactive Lysis) ie CD59 . DAF prevents the formation of C3 convertases , and CD59 inhibits the formation of the membrane attack complex . Acquired deficiency can lead to paroxysmal nocturnal hemoglobinuria (PNH) . Complement Factor H inhibits the alternative pathway by promoting the cleavage and destruction of C3b and the turnover of the C3 convertases . Inherited defects in Factor H cause an atypical form of Hemolytic Uremic Syndrome .</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Options A, C, D are incorrect</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "deb18ae9",
      "audio": ""
    },
    {
      "text": "Endogenous chemoattractant is-",
      "options": [
        {
          "label": "A",
          "text": "C5a",
          "correct": true
        },
        {
          "label": "B",
          "text": "Bacterial products",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lipopolysaccharide A",
          "correct": false
        },
        {
          "label": "D",
          "text": "C8",
          "correct": false
        }
      ],
      "correct_answer": "A. C5a",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>C5a After exiting the circulation, leukocytes move in the tissues toward the site of injury by chemotaxis, defined as locomotion along a chemical gradient . Both exogenous and endogenous substances can act as chemoattractants . The most common exogenous agents are bacterial products , including peptides that possess an N-formyl methionine terminal amino acid and some lipids. Endogenous chemoattractants include several chemical mediators, including cytokines (e.g., IL-8 ), Components of the complement system (particularly C5a ) and arachidonic acid metabolites, mainly leukotriene B4 (LTB4) . This induces the polymerisation of actin at the leading edge of the cell, which allows the leading edge of the leukocyte to extend filopodia and results in Chemotaxis .</p>\n<p><strong>Highyeild:</strong></p><p>Cellular events of inflammation: Margination: WBC movement inside the lumen of a blood vessel. Occurs due to selectins . Rolling: WBC movement inside the lumen of a blood vessel. Occurs due to selectins (endothelium) and Sialyl Lewis X glycoprotein (WBC) . Adhesion: WBC movement inside the lumen of a blood vessel. Occurs due to ICAM and VCAM (endothelium) and \u03b22 Integrins (WBC) . Diapedesis: WBC moves across the Occurs due to PECAM-1, aka CD31 . Chemotaxis: Movement of WBC along a chemical gradient.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Options B, C, D are incorrect</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7c7782e7",
      "audio": ""
    },
    {
      "text": "Complement responsible for activation of bacterial lysis is-",
      "options": [
        {
          "label": "A",
          "text": "C3a",
          "correct": false
        },
        {
          "label": "B",
          "text": "C3b",
          "correct": false
        },
        {
          "label": "C",
          "text": "C5-9",
          "correct": true
        },
        {
          "label": "D",
          "text": "C5a",
          "correct": false
        }
      ],
      "correct_answer": "C. C5-9",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>C5-9 Membrane attack complex is responsible for cell lysis . It consists of C-5,6,7,8,9 complement proteins . Complement activation on cells also leads to the formation of the membrane attack complex, which disrupts membrane integrity by \u201c drilling holes \u201d through the lipid bilayer, thereby causing osmotic lysis of the cells . Deficiency of these late-acting components is associated with increased susceptibility to recurrent Neisseria (gonococcal and meningococcal) infections.</p>\n<p><strong>Highyeild:</strong></p><p>The critical step in complement activation is the proteolysis of the third (and most abundant) component, C3 . Cleavage of C3 can occur by one of three pathways: Classical pathway Alternative pathway Lectin pathway The complement system has three main functions: Inflammation Opsonization and phagocytosis Cell lysis The activation of complement is tightly controlled by cell-associated and circulating regulatory proteins . Regulatory proteins can be overwhelmed when large amounts of complement are deposited on host cells and tissues. The most important of these regulatory proteins are the following: C1 inhibitor: blocks the activation of C1, the first protein of the classical complement pathway. Inherited deficiency of this inhibitor is the cause of hereditary angioedema . Decay accelerating factor (DAF) ie CD55 and MIRL (Membrane Inhibitor of Reactive Lysis) ie CD59 . DAF prevents the formation of C3 convertases , and CD59 inhibits the formation of the membrane attack complex . Acquired deficiency can lead to paroxysmal nocturnal hemoglobinuria (PNH) . Complement Factor H inhibits the alternative pathway by promoting the cleavage and destruction of C3b and the turnover of the C3 convertases . Inherited defects in Factor H cause an atypical form of Hemolytic Uremic Syndrome .</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Options A, B, D are incorrect</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "244b7335",
      "audio": ""
    },
    {
      "text": "All are correct, except?",
      "options": [
        {
          "label": "A",
          "text": "Cause of aspirin-sensitive asthma is overproduction of leukotrienes due to COX inhibition",
          "correct": false
        },
        {
          "label": "B",
          "text": "Complement C5a acts as a chemokine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Complement C3b acts as an opsonizer",
          "correct": false
        },
        {
          "label": "D",
          "text": "Fibrinogen and C reactive proteins are negative acute phase reactants",
          "correct": true
        }
      ],
      "correct_answer": "D. Fibrinogen and C reactive proteins are negative acute phase reactants",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Fibrinogen and C reactive proteins are negative acute phase reactants Positive Acute Phase Reactants increase during inflammation. CRP and Fibrinogen are negative acute phase reactants. Elevated levels of acute-phase proteins (APR) , which are plasma proteins , mostly synthesized in the liver , whose plasma concentrations may increase several hundred\u2013fold as part of the response to inflammatory stimuli.</p>\n<p><strong>Highyeild:</strong></p><p>Acute Phase Reactants: Positive Acute Phase Reactants Negative Acute Phase Reactants Fibrinogen Transferrin CRP Albumin Ferritin Transthyretin Haptoglobin Hepcidin Ceruloplasmin Serum amyloid (SAA)</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Cause of aspirin-sensitive asthma is overproduction of leukotrienes as a result of COX inhibition. There will be a divergence of arachidonic acid metabolites towards LOX pathway as a result of COX inhibition, causing Aspirin-induced Asthma . Option: B. Complement C5a acts as a chemokine. True . Option: C. Complement C3b acts as an opsonizer. True .</p>\n<p><strong>Extraedge:</strong></p><p>Elevated serum levels of CRP have been proposed as a marker for increased risk of myocardial infarction in patients with coronary artery disease. It is postulated that inflammation involving atherosclerotic plaques in the coronary arteries may predispose to thrombosis and subsequent infarction. Hepcidin is a small protein that reduces the availability of iron to erythroid progenitors in the bone marrow; over time, this effect may lead to anemia or chronic inflammation . Thrombopoietin , the major growth factor for megakaryocytes (platelet precursors) in the bone marrow, is also upregulated and as a result systemic inflammation may be associated with an elevated platelet count ( thrombocytosis ). Acute-phase proteins have beneficial effects during acute inflammation, but prolonged production of these proteins (especially SAA ) in states of chronic inflammation causes secondary amyloidosis .</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "659d7c31",
      "audio": ""
    },
    {
      "text": "A 72-year-old female reports that approximately 2 weeks ago, she noticed the onset of decreased vision in her left eye associated with a \u201cblack spot\u201d close to the centre of her vision. The spot is present with both near and far vision and does not move away. The vision has been slightly blurred for a while. She denies any recent trauma, eye pain, redness or discharge. Peripheral vision is normal. The visual field she has is depicted below. This is correlated to which of the following?",
      "options": [
        {
          "label": "A",
          "text": "CD59 deficiency",
          "correct": false
        },
        {
          "label": "B",
          "text": "Factor H polymorphism",
          "correct": true
        },
        {
          "label": "C",
          "text": "C1 inhibitor deficiency",
          "correct": false
        },
        {
          "label": "D",
          "text": "Decay accelerating factor deficiency",
          "correct": false
        }
      ],
      "correct_answer": "B. Factor H polymorphism",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/questionImage-1686815879658-QTDP019046IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Factor H polymorphism Complement Factor H is a circulating glycoprotein that inhibits the alternative pathway of complement activation by promoting the cleavage and destruction of C3b and the turnover of the C3 convertases . Inherited defects in Factor H and several other regulatory proteins that interact with Factor H cause an atypical form of the hemolytic uremic syndrome , in which complement deposits in glomerular vessels lead to endothelial damage and the formation of platelet-rich thrombi . Polymorphisms in the Factor H gene have also been linked to age-related macular degeneration , an important cause of vision loss in older adults.</p>\n<p><strong>Highyeild:</strong></p><p>The critical step in complement activation is the proteolysis of the third (and most abundant) component, C3 . Cleavage of C3 can occur by one of three pathways: Classical pathway Alternative pathway Lectin pathway The complement system has three main functions: Inflammation Opsonization and phagocytosis Cell lysis The activation of complement is tightly controlled by cell-associated and circulating regulatory proteins . Regulatory proteins can be overwhelmed when large amounts of complement are deposited on host cells and tissues. The most important of these regulatory proteins are the following: C1 inhibitor: blocks the activation of C1, the first protein of the classical complement pathway. Inherited deficiency of this inhibitor is the cause of hereditary angioedema . Decay accelerating factor (DAF) ie CD55 and MIRL (Membrane Inhibitor of Reactive Lysis) ie CD59 . DAF prevents the formation of C3 convertases , and CD59 inhibits the formation of the membrane attack complex . Acquired deficiency can lead to paroxysmal nocturnal hemoglobinuria (PNH) . Complement Factor H inhibits the alternative pathway by promoting the cleavage and destruction of C3b and the turnover of the C3 convertases . Inherited defects in Factor H cause an atypical form of Hemolytic Uremic Syndrome .</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. CD59 deficiency. Deficiency leads to PNH . Option: C. C1 inhibitor deficiency. Deficiency leads to hereditary angioedema . Option: D. Decay accelerating factor deficiency. Deficiency leads to PNH .</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b2e008df",
      "audio": ""
    }
  ]
}